CONMED Corp — Director's Dealing 2013

Jun 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-06-01

Reporting Person: ABRAHAM WILLIAM (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-01	Common Stock	M	200	—	Acquired	18135	Direct
2013-06-01	Common Stock	F	73	$32.93	Disposed	18062	Direct
2013-06-01	Common Stock	M	400	—	Acquired	18462	Direct
2013-06-01	Common Stock	F	145	$32.93	Disposed	18317	Direct
2013-06-01	Common Stock	M	400	—	Acquired	18717	Direct
2013-06-01	Common Stock	F	145	$32.93	Disposed	18572	Direct
2013-06-01	Common Stock	M	400	—	Acquired	18972	Direct
2013-06-01	Common Stock	F	145	$32.93	Disposed	18827	Direct
2013-06-01	Common Stock	M	400	—	Acquired	19227	Direct
2013-06-01	Common Stock	F	145	$32.93	Disposed	19082	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-06-01	Rsus (restricted Stock Units)	$0	M	200	Disposed	2018-06-01	Common Stock (200)	Direct
2013-06-01	Rsus (restricted Stock Units)	$0	M	400	Disposed	2019-06-01	Common Stock (400)	Direct
2013-06-01	Rsus (restricted Stock Units)	$0	M	400	Disposed	2020-06-01	Common Stock (400)	Direct
2013-06-01	Rsus (restricted Stock Units)	$0	M	400	Disposed	2021-06-01	Common Stock (400)	Direct
2013-06-01	Rsus (restricted Stock Units)	$0	M	400	Disposed	2022-06-01	Common Stock (400)	Direct
2013-06-01	Rsus (restricted Stock Units)	$0	A	2000	Acquired	2023-06-01	Common Stock (2000)	Direct
2013-06-01	Sars (Stock Appreciation Rights)	$32.93	A	5000	Acquired	2023-06-01	Common Stock (5000)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.